Drug intelligence / Profile preview

clavulanic acid + dexamethasone

Development stage
Unknown
Lead developer
Dexon Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Clavulanic acid + dexamethasone is a non-standard combination of a beta-lactamase inhibitor and a corticosteroid. Clavulanic acid is a suicide inhibitor of bacterial beta-lactamase enzymes, typically used in combination with beta-lactam antibiotics like amoxicillin to prevent antibiotic resistance. Dexamethasone is a potent synthetic glucocorticoid used for its anti-inflammatory and immunosuppressive properties. There is no evidence of a commercially available or clinical-stage fixed-dose combination containing only these two ingredients. The mention of this combination likely results from a misinterpretation of the brand name **CLAVODEX**, which is a generic formulation of amoxicillin and clavulanic acid marketed by Dexon Biotech; in this instance, the **DEX** suffix is derived from the company name rather than an indication of dexamethasone content.

02

Targets

GR (Glucocorticoid receptor)Neuraminidase

Beyond the preview

Go deeper on clavulanic acid + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clavulanic acid + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call